Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 2021 Jan;46(1):145-146.
doi: 10.1111/ced.14411. Epub 2020 Oct 8.

Reduction in skin cancer diagnoses in the UK during the COVID-19 pandemic

T W Andrew  1 , M Alrawi  1 , P Lovat  2
Affiliations
Comparative Study

Reduction in skin cancer diagnoses in the UK during the COVID-19 pandemic

T W Andrew et al. Clin Exp Dermatol. 2021 Jan.

Abstract

The UK healthcare system, including skin cancer departments, has been profoundly affected by the COVID-19 pandemic. Despite service capacity and a worldwide increase in incidence, anecdotal reports suggest a decline in skin cancer diagnoses following COVID-19. To determine if there has been a decrease in skin cancer diagnosis in the UK in the COVID-19 era, we analysed data from the Northern Cancer Network from 23 March 2020 to 23 June 2020 and compared it with the same period in 2019 (pre-COVID). In the COVID period, there was a decrease of 68.61% in skin cancer diagnoses, from 3619 to 1136 (P < 0.01). Surprisingly, skin cancer waiting times were also reduced in the COVID period compared to the pre-COVID period (median of 8 and 12 days, respectively; P < 0.001). Collectively, these data highlight a statistically significant reduction in both skin cancer diagnoses and waiting times during the COVID period.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Comparison of skin cancer diagnoses and waiting times between the pre‐COVID and COVID periods. (a, b) Column charts representing (a) mean (and SEM) number of skin cancer diagnoses per month in a cohort of 4755 patients included in the Northern Cancer Network, and (b) median (and 95% CI) waiting time of skin cancer referrals to first appointment. **P < 0.01; ***P < 0.001.
See this image and copyright information in PMC

References

    1. Improvement NHS England and NHS. Important and urgent – next steps on NHS response to COVID‐19. Available at: https://www.england.nhs.uk/coronavirus/wp‐content/uploads/sites/52/2020/... (accessed 2 April 2020).
    1. British Association of Dermatologists. Clinical guidance for the management of skin cancer patients during the coronavirus pandemic. Available at: https://www.bad.org.uk/shared/get‐file.ashx?itemtype=document&id=6670 (accessed 2 April 2020).
    1. Garcia S, Albaghdadi MS, Meraj PM et al. Reduction in ST‐segment elevation cardiac catheterization laboratory activations in the United States during COVID‐19 pandemic. J Am Coll Cardiol 2020; 75: 2871–2. - PMC - PubMed
    1. Chuchu N, Dinnes J, Takwoingi Y et al. Teledermatology for diagnosing skin cancer in adults. Cochrane Database Syst Rev 2018; 12: CD013193. - PMC - PubMed
    1. Hanna TP, Evans GA, Booth CM. Cancer, COVID‐19 and the precautionary principle: prioritizing treatment during a global pandemic. Nat Rev Clin Oncol 2020; 17: 268–70. - PMC - PubMed

Publication types

LinkOut - more resources